5-FLUOROURACIL TOXICITY

Clinical trials for 5-FLUOROURACIL TOXICITY explained in plain language.

Never miss a new study

Get alerted when new 5-FLUOROURACIL TOXICITY trials appear

Sign up with your email to follow new studies for 5-FLUOROURACIL TOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Completed 1

Can a common supplement shield your liver from chemo damage?

Disease control Not yet recruiting

This study is testing if a dietary supplement called SAMe can prevent liver damage caused by a common chemotherapy drug (oxaliplatin) in patients with colorectal cancer that has spread to the liver. About 30 patients will take SAMe pills daily during their 3-6 months of chemother…

Matched conditions: 5-FLUOROURACIL TOXICITY

Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control

Last updated Mar 09, 2026 14:22 UTC

5-FLUOROURACIL TOXICITY

Get alerted when new 5-FLUOROURACIL TOXICITY trials appear

Can a common supplement shield your liver from chemo damage?